Inside a research in breast cancer cells, the combination of lapatinib, a dual HER2/neu and EGFR tyrosine kinase inhibitor, with INK128 prevented each HER2 and HER3 phosphorylation induced by INK128 and made synergistic induction of cell death in numerous HER2-optimistic mobile strains immune to trastuzumab and lapatinib. In vivo Inside https://andersonn429ekp3.wikirecognition.com/user